|
|
Article: Constricted Budgets and Consolidation Check Growth of Nucleic Acid Isolation Market.
- Article from:
- Business Wire
- Article date:
- October 15, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 15, 2003
Biotechnology and pharmaceutical companies are likely to tighten their budgets with the phasing out of blockbuster drugs. This is detrimental to the interests of nucleic acid isolation companies, which are significantly dependent on them for sales.
New analysis from Frost & Sullivan (http://www.biotech.frost.com), U.S. Nucleic Acid Isolation Markets, reveals that this industry generated revenues totaling $233 million in 2002. Total market revenues are expected to reach $503 million in 2009.
Both instrumentation and consumables sectors of the ...